Literature DB >> 27599502

Exogenous heat shock protein HSP70 reduces response of human neuroblastoma cells to lipopolysaccharide.

M M Yurinskaya1,2, S Y Funikov2, M B Evgen'ev1,2, M G Vinokurov3.   

Abstract

The effect of exogenous heat shock protein HSP70 and lipopolysaccharide (LPS) on the production of reactive oxygen species (ROS), TNFα secretion, and mRNA expression by human neuroblastoma SK-N-SH cells. It was shown that exogenous HSP70 protects neuroblastoma cells from the action of LPS. The protection mechanism of HSP70 includes a reduction in the production of ROS and TNFα and a decrease in the expression of TLR4 and IL-1β mRNA in SK-N-SH cells induced by LPS.

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27599502     DOI： 10.1134/S1607672916040025

Source DB:  PubMed          Journal:  Dokl Biochem Biophys        ISSN： 1607-6729            Impact factor:   0.788


  15 in total

1.  Poxviral protein A46 antagonizes Toll-like receptor 4 signaling by targeting BB loop motifs in Toll-IL-1 receptor adaptor proteins to disrupt receptor:adaptor interactions.

Authors:  Julianne Stack; Andrew G Bowie
Journal:  J Biol Chem       Date:  2012-05-16       Impact factor: 5.157

2.  [Heat-shock protein HSP70 protects neuroblastoma cells SK-N-SH from the neurotoxic effects hydrogen peroxide and the β-amyloid peptide].

Authors:  M M Yurinskaya; V A Mit'kevich; E P Barykin; D G Garbuz; M B Evgen'ev; A A Makarov; M G Vinokurov
Journal:  Mol Biol (Mosk)       Date:  2015 Nov-Dec

3.  Wogonin inhibits LPS-induced inflammatory responses in rat dorsal root ganglion neurons via inhibiting TLR4-MyD88-TAK1-mediated NF-κB and MAPK signaling pathway.

Authors:  Shibiao Chen; Jiangqin Xiong; Yanping Zhan; Weicheng Liu; Xiuhong Wang
Journal:  Cell Mol Neurobiol       Date:  2014-12-14       Impact factor: 5.046

4.  The Fate of Exogenous Human HSP70 Introduced into Animal Cells by Different Means.

Authors:  Marina Yurinskaya; Olga G Zatsepina; Maxim G Vinokurov; Natalia V Bobkova; David G Garbuz; Alexei V Morozov; Dina A Kulikova; Vladimir A Mitkevich; Alexander A Makarov; Sergei Yu Funikov; Michael B Evgen'ev
Journal:  Curr Drug Deliv       Date:  2015       Impact factor: 2.565

5.  Novel signal transduction pathway utilized by extracellular HSP70: role of toll-like receptor (TLR) 2 and TLR4.

Authors:  Alexzander Asea; Michael Rehli; Edith Kabingu; Jason A Boch; Olivia Bare; Philip E Auron; Mary Ann Stevenson; Stuart K Calderwood
Journal:  J Biol Chem       Date:  2002-02-08       Impact factor: 5.157

Review 6.  Biological role of Toll-like receptor-4 in the brain.

Authors:  Teresa Trotta; Chiara Porro; Rosa Calvello; Maria Antonietta Panaro
Journal:  J Neuroimmunol       Date:  2014-02-04       Impact factor: 3.478

7.  Efficient generation of infectious recombinant baculoviruses by site-specific transposon-mediated insertion of foreign genes into a baculovirus genome propagated in Escherichia coli.

Authors:  V A Luckow; S C Lee; G F Barry; P O Olins
Journal:  J Virol       Date:  1993-08       Impact factor: 5.103

8.  Intracellular expression of toll-like receptor 4 in neuroblastoma cells and their unresponsiveness to lipopolysaccharide.

Authors:  Ferdaus Hassan; Shamima Islam; Gantsetseg Tumurkhuu; Yoshikazu Naiki; Naoki Koide; Isamu Mori; Tomoaki Yoshida; Takashi Yokochi
Journal:  BMC Cancer       Date:  2006-12-08       Impact factor: 4.430

Review 9.  Neuroinflammation in motor neuron disease.

Authors:  Okiru Komine; Koji Yamanaka
Journal:  Nagoya J Med Sci       Date:  2015-11       Impact factor: 1.131

10.  HSP70 protects human neuroblastoma cells from apoptosis and oxidative stress induced by amyloid peptide isoAsp7-Aβ(1-42).

Authors:  M M Yurinskaya; V A Mitkevich; S A Kozin; M B Evgen'ev; A A Makarov; M G Vinokurov
Journal:  Cell Death Dis       Date:  2015-11-19       Impact factor: 8.469
View more
  1 in total

1.  Expression of heat shock protein 70 and Annexin A1 in serum of patients with acutely severe traumatic brain injury.

Authors:  Junjing Zhao; Tao Wang; Qiming Lv; Nan Zhou
Journal:  Exp Ther Med       Date:  2019-12-20       Impact factor: 2.447
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.